Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Rossari Biotech Ltd (IN:ROSSARI)

:ROSSARI

ROSSARI

Rossari Biotech Ltd

RESEARCH TOOLSreports

Rossari Biotech Ltd (ROSSARI) Ratios

Compare

2 Followers

Rossari Biotech Ltd Ratios

IN:ROSSARI's free cash flow for Q2 2026 was ₹0.22. For the 2026 fiscal year, IN:ROSSARI's free cash flow was decreased by ₹ and operating cash flow was ₹0.09. See a summary of the company’s cash flow.

Ratios	TTM	Mar 25	Mar 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	1.73	1.94	1.99	2.08	2.07
Quick Ratio	1.14	1.28	1.32	1.54	1.42
Cash Ratio	0.08	0.11	0.06	0.20	0.13
Solvency Ratio	0.25	0.29	0.36	0.38	0.32
Operating Cash Flow Ratio	-0.04	0.26	0.10	0.44	0.10
Short-Term Operating Cash Flow Coverage	-0.12	1.56	0.60	3.89	3.48
Net Current Asset Value	₹ 2.78B	₹ 3.32B	₹ 3.19B	₹ 2.69B	₹ 1.58B
Leverage Ratios
Debt-to-Assets Ratio	0.17	0.11	0.08	0.05	<0.01
Debt-to-Equity Ratio	0.28	0.18	0.11	0.08	0.01
Debt-to-Capital Ratio	0.22	0.16	0.10	0.07	0.01
Long-Term Debt-to-Capital Ratio	0.09	0.08	0.03	0.04	0.00
Financial Leverage Ratio	1.67	1.60	1.50	1.49	1.56
Debt Service Coverage Ratio	0.98	2.05	2.29	2.85	7.36
Interest Coverage Ratio	11.83	28.90	9.63	6.95	10.43
Debt to Market Cap	0.15	0.06	0.03	0.02	<0.01
Interest Debt Per Share	68.19	42.59	25.03	17.46	3.84
Net Debt to EBITDA	1.07	0.61	0.36	0.02	-0.15
Profitability Margins
Gross Profit Margin	26.21%	31.10%	28.76%	16.88%	15.42%
EBIT Margin	9.09%	9.52%	10.76%	9.16%	9.82%
EBITDA Margin	12.24%	12.74%	14.05%	12.79%	13.06%
Operating Profit Margin	12.90%	24.74%	10.19%	9.36%	8.90%
Pretax Profit Margin	8.12%	8.90%	9.70%	8.71%	9.19%
Net Profit Margin	6.01%	6.56%	7.14%	6.48%	6.59%
Continuous Operations Profit Margin	6.01%	6.56%	7.14%	6.48%	6.59%
Net Income Per EBT	74.04%	73.64%	73.58%	74.37%	71.67%
EBT Per EBIT	62.94%	35.98%	95.18%	93.04%	103.21%
Return on Assets (ROA)	6.59%	7.19%	8.31%	7.84%	7.77%
Return on Equity (ROE)	11.62%	11.50%	12.47%	11.72%	12.13%
Return on Capital Employed (ROCE)	20.47%	37.85%	16.26%	15.19%	13.72%
Return on Invested Capital (ROIC)	13.21%	26.04%	11.24%	10.88%	9.75%
Return on Tangible Assets	7.43%	8.26%	9.98%	9.80%	9.80%
Earnings Yield	6.40%	4.00%	3.38%	3.26%	1.95%
Efficiency Ratios
Receivables Turnover	4.23	4.37	4.30	4.67	4.84
Payables Turnover	5.78	5.01	5.95	7.60	5.97
Inventory Turnover	4.43	4.04	4.62	7.30	5.85
Fixed Asset Turnover	3.72	3.74	4.31	5.07	4.26
Asset Turnover	1.10	1.10	1.16	1.21	1.18
Working Capital Turnover Ratio	9.76	4.50	4.62	4.81	5.71
Cash Conversion Cycle	105.47	101.03	102.64	80.12	76.65
Days of Sales Outstanding	86.34	83.52	84.94	78.14	75.40
Days of Inventory Outstanding	82.30	90.42	79.02	49.99	62.41
Days of Payables Outstanding	63.18	72.92	61.32	48.01	61.17
Operating Cycle	168.65	173.95	163.96	128.13	137.81
Cash Flow Ratios
Operating Cash Flow Per Share	-4.52	24.82	7.83	27.50	5.35
Free Cash Flow Per Share	-30.12	-3.81	-15.94	21.69	-1.62
CapEx Per Share	25.60	28.63	23.78	5.97	6.97
Free Cash Flow to Operating Cash Flow	6.66	-0.15	-2.04	0.79	-0.30
Dividend Paid and CapEx Coverage Ratio	-0.17	0.85	0.32	4.25	0.72
Capital Expenditure Coverage Ratio	-0.18	0.87	0.33	4.61	0.77
Operating Cash Flow Coverage Ratio	-0.07	0.63	0.36	2.05	3.48
Operating Cash Flow to Sales Ratio	-0.01	0.07	0.02	0.09	0.02
Free Cash Flow Yield	-7.75%	-0.62%	-2.28%	3.64%	-0.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	15.64	25.01	29.57	30.63	51.19
Price-to-Sales (P/S) Ratio	0.94	1.64	2.11	1.98	3.37
Price-to-Book (P/B) Ratio	1.72	2.88	3.69	3.59	6.21
Price-to-Free Cash Flow (P/FCF) Ratio	-12.91	-161.88	-43.90	27.49	-563.88
Price-to-Operating Cash Flow Ratio	-86.01	24.81	89.33	21.68	170.31
Price-to-Earnings Growth (PEG) Ratio	20.31	5.98	1.37	3.31	3.58
Price-to-Fair Value	1.72	2.88	3.69	3.59	6.21
Enterprise Value Multiple	8.75	13.47	15.39	15.53	25.66
Enterprise Value	24.54B	35.71B	39.58B	32.89B	49.71B
EV to EBITDA	8.75	13.47	15.39	15.53	25.66
EV to Sales	1.07	1.72	2.16	1.99	3.35
EV to Free Cash Flow	-14.71	-169.51	-44.96	27.52	-560.61
EV to Operating Cash Flow	-98.02	25.98	91.50	21.70	169.32
Tangible Book Value Per Share	183.67	169.88	142.16	116.51	99.30
Shareholders’ Equity Per Share	225.98	214.09	189.77	166.05	146.80
Tax and Other Ratios
Effective Tax Rate	0.26	0.26	0.26	0.26	0.28
Revenue Per Share	413.69	375.70	331.56	300.44	270.38
Net Income Per Share	24.86	24.63	23.67	19.46	17.81
Tax Burden	0.74	0.74	0.74	0.74	0.72
Interest Burden	0.89	0.94	0.90	0.95	0.94
Research & Development to Revenue	<0.01	<0.01	<0.01	<0.01	<0.01
SG&A to Revenue	0.00	0.01	<0.01	<0.01	0.01
Stock-Based Compensation to Revenue	<0.01	<0.01	<0.01	<0.01	<0.01
Income Quality	-0.15	1.01	0.33	1.05	0.22

Currency in INR